Tertiary lymphoid structures in hepatocellular carcinoma: Prognostic biomarker, immunotherapy predictor, and emerging therapeutic target

Mehriban Bazar, Ye Tian, Haijing Luan, Lin Zhang, Qian Lu, Liang Wang, Xiaojuan Wang, Jiahong Dong

Open source

DOI
10.1016/j.canlet.2026.218798
Published
2026-11
Container
Cancer Letters
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.canlet.2026.218798,
  title = {Tertiary lymphoid structures in hepatocellular carcinoma: Prognostic biomarker, immunotherapy predictor, and emerging therapeutic target},
  author = {Mehriban Bazar and Ye Tian and Haijing Luan and Lin Zhang and Qian Lu and Liang Wang and Xiaojuan Wang and Jiahong Dong},
  year = {2026},
  journal = {Cancer Letters},
  doi = {10.1016/j.canlet.2026.218798},
  url = {https://doi.org/10.1016/j.canlet.2026.218798}
}

RIS

TY  - JOUR
TI  - Tertiary lymphoid structures in hepatocellular carcinoma: Prognostic biomarker, immunotherapy predictor, and emerging therapeutic target
AU  - Mehriban Bazar
AU  - Ye Tian
AU  - Haijing Luan
AU  - Lin Zhang
AU  - Qian Lu
AU  - Liang Wang
AU  - Xiaojuan Wang
AU  - Jiahong Dong
PY  - 2026
JO  - Cancer Letters
DO  - 10.1016/j.canlet.2026.218798
UR  - https://doi.org/10.1016/j.canlet.2026.218798
ER  - 

APA

Bazar, M., Tian, Y., Luan, H., Zhang, L., Lu, Q., Wang, L., Wang, X., & Dong, J. (2026). Tertiary lymphoid structures in hepatocellular carcinoma: Prognostic biomarker, immunotherapy predictor, and emerging therapeutic target. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218798

Source records